Loading clinical trials...
Loading clinical trials...
Safety and Pharmacokinetic Evaluation of Zika Virus Immune Globulin in Healthy Volunteers
Conditions
Interventions
Zika Virus Immune Globulin (ZIKV-IG)
Placebo
Locations
1
Canada
Syneos Health, Early Phase
Toronto, Ontario, Canada
Start Date
June 27, 2018
Primary Completion Date
March 6, 2019
Completion Date
March 6, 2019
Last Updated
March 18, 2024
Lead Sponsor
Emergent BioSolutions
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions